Skip to main content

Moderna, Inc.

MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001682852

In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Moderna, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
4 insiders, $49.2M in total
Insiders trading
4
Net value
−$49.2M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Moderna, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Moderna, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hoge StephenPresident1,562,029Sep 16, 202613
Mock James MChief Financial Officer59,375Sep 14, 202616
Klinger Shannon ThymeChief Legal Officer81,340Sep 8, 202612
Bancel StephaneChief Executive Officer6,440,260Aug 7, 20264
McDonnell Michael RDirector–Jul 10, 20261
Banque Soria EsterChief Commercial Officer–Jul 7, 20261
Afeyan NoubarDirector3,924IndirectMay 22, 20263
Tallett Elizabeth EDirector4,761May 8, 20262
Nader FrancoisDirector32,781May 8, 20262
Rubenstein David M.Director9,643May 8, 20262
Nabel Elizabeth GDirector19,317May 8, 20262
Horning SandraDirector18,585May 8, 20262
Hussain AbbasDirector12,066May 8, 20264
Sagan PaulDirector312,027IndirectMay 1, 20250
Langer RobertDirector11,467,664May 7, 20240
Berenson StephenDirector22,203May 7, 20240
Garay ArpaChief Commercial Officer3,690Dec 7, 20230
Andres JuanSee remarks12,803Dec 30, 20220
Burton PaulChief Medical Officer954Nov 8, 20220
Meline David WChief Financial Officer2,857Aug 11, 20220
Zaks Tal ZviChief Medical Officer0Jul 2, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 16, 2026 (view filing)4:48 PM ETSep 14-152 daysHoge StephenPresidentSSale−80.6K$145.10−$11.7M−4.9%1.56M after2 lots10b5-1
Sep 14, 2026 (view filing)4:25 PM ETSep 104 daysMock James MChief Financial OfficerSSale−34.8K$134.49−$4.69M−37.0%59.4K after2 lots10b5-1
Sep 3, 2026 (view filing)4:56 PM ETSep 12 daysKlinger Shannon ThymeChief Legal OfficerSSale−3.47K$139.95−$485.8K−4.5%74.1K after10b5-1
Aug 7, 2026 (view filing)4:11 PM ETAug 52 daysBancel StephaneChief Executive OfficerSSale−499.2K$57.52−$28.7M−7.5%6.19M after4 lots10b5-1
Jul 16, 2026 (view filing)4:45 PM ETJul 151 dayHoge StephenPresidentSSale−53.3K$67.60−$3.61M−3.5%1.48M after10b5-1
Jun 17, 2026 (view filing)Jun 152 daysHoge StephenPresidentSSale−53.3K$51.37−$2.74M−3.5%1.48M after10b5-1
Jun 8, 2026 (view filing)Jun 44 daysKlinger Shannon ThymeChief Legal OfficerSSale−3.47K$50.00−$173.6K−4.9%67.5K after10b5-1
May 22, 2026 (view filing)May 211 dayAfeyan NoubarDirectorSSale−9.26K$46.84−$433.9K−70.2%3.92K after
May 18, 2026 (view filing)May 153 daysHoge StephenPresidentSSale−53.3K$48.40−$2.58M−3.5%1.48M after10b5-1
May 4, 2026 (view filing)May 13 daysHussain AbbasDirectorSSale−5.68K$46.63−$265.0K−32.0%12.1K after10b5-1
Mar 3, 2026 (view filing)Mar 21 dayKlinger Shannon ThymeChief Legal OfficerSSale−13.9K$52.29−$726.0K−18.9%59.7K after10b5-1
Feb 25, 2026 (view filing)Feb 232 daysHoge StephenPresidentSSale−160.0K$48.84−$7.81M−9.9%1.46M after10b5-1
Dec 15, 2025 (view filing)Dec 114 daysAfeyan NoubarDirectorSSale−23.9K$29.49−$703.4K−85.9%3.92K after
Dec 11, 2025 (view filing)Dec 92 daysHussain AbbasDirectorSSale−504$27.60−$13.9K−25.0%1.51K after10b5-1
Jun 12, 2025 (view filing)Jun 111 dayHussain AbbasDirectorSSale−312$28.00−$8.74K−35.0%580 after10b5-1
Mar 4, 2025 (view filing)Mar 31 dayBancel StephaneChief Executive OfficerPPurchase+160.3K$31.22+$5.00M+1.8%9.21M after2 lots
Mar 4, 2025 (view filing)Mar 31 daySagan PaulDirectorPPurchase+31.6K$31.76+$1.00M+11.3%312.0K after
Dec 10, 2024 (view filing)Dec 91 dayKlinger Shannon ThymeChief Legal OfficerSSale−529$44.68−$23.6K−2.5%20.4K after10b5-1
Dec 4, 2024 (view filing)Dec 31 dayKlinger Shannon ThymeChief Legal OfficerSSale−112$43.30−$4.85K−0.6%19.8K after10b5-1
Dec 4, 2024 (view filing)Dec 31 dayHoge StephenPresidentSSale−314$43.30−$13.6K0.0%1.44M after10b5-1
Dec 2, 2024 (view filing)Nov 293 daysMock James MChief Financial OfficerSSale−1.42K$42.79−$60.8K−11.4%11.1K after10b5-1
Dec 2, 2024 (view filing)Nov 293 daysKlinger Shannon ThymeChief Legal OfficerSSale−1.42K$42.79−$60.7K−6.7%19.7K after10b5-1
Dec 2, 2024 (view filing)Nov 293 daysHoge StephenPresidentSSale−291$42.79−$12.5K0.0%1.44M after10b5-1
Nov 12, 2024 (view filing)Nov 111 dayHoge StephenPresidentSSale−277$46.10−$12.8K0.0%1.44M after10b5-1
Oct 8, 2024 (view filing)Oct 71 dayMock James MChief Financial OfficerSSale−715$60.12−$43.0K−7.0%9.51K after10b5-1
Sep 10, 2024 (view filing)Sep 91 dayKlinger Shannon ThymeChief Legal OfficerSSale−551$73.57−$40.5K−2.9%18.2K after10b5-1
Sep 4, 2024 (view filing)Sep 31 dayKlinger Shannon ThymeChief Legal OfficerSSale−114$76.99−$8.78K−0.6%17.6K after10b5-1
Sep 4, 2024 (view filing)Sep 31 dayHoge StephenPresidentSSale−318$76.99−$24.5K0.0%1.44M after10b5-1
Aug 30, 2024 (view filing)Aug 291 dayMock James MChief Financial OfficerSSale−162$78.03−$12.6K−1.8%8.77K after10b5-1
Aug 30, 2024 (view filing)Aug 291 dayKlinger Shannon ThymeChief Legal OfficerSSale−162$78.03−$12.6K−0.9%17.4K after10b5-1
Aug 30, 2024 (view filing)Aug 291 dayHoge StephenPresidentSSale−300$78.03−$23.4K0.0%1.44M after10b5-1
Aug 29, 2024 (view filing)Aug 281 dayMock James MChief Financial OfficerSSale−1.32K$79.39−$104.9K−13.3%8.60K after10b5-1
Aug 29, 2024 (view filing)Aug 281 dayKlinger Shannon ThymeChief Legal OfficerSSale−1.32K$79.39−$104.7K−7.1%17.3K after10b5-1
Aug 13, 2024 (view filing)Aug 121 dayHoge StephenPresidentSSale−254$84.10−$21.4K0.0%1.44M after10b5-1
Aug 2, 2024 (view filing)Jul 312 daysAfeyan NoubarDirectorSSale−15.0K$119.96−$1.80M−0.7%2.22M after4 lots10b5-1
Jul 26, 2024 (view filing)Jul 242 daysAfeyan NoubarDirectorSSale−15.0K$117.80−$1.77M−0.7%2.24M after4 lots10b5-1
Jul 19, 2024 (view filing)Jul 172 daysAfeyan NoubarDirectorSSale−15.0K$122.84−$1.84M−0.7%2.25M after5 lots10b5-1
Jul 16, 2024 (view filing)Jul 151 dayHoge StephenPresidentSSale−15.0K$121.12−$1.82M−1.0%1.44M after10b5-1
Jul 12, 2024 (view filing)Jul 102 daysAfeyan NoubarDirectorSSale−15.0K$117.08−$1.76M−0.7%2.27M after5 lots10b5-1
Jul 9, 2024 (view filing)Jul 81 dayMock James MChief Financial OfficerSSale−689$118.24−$81.5K−8.7%7.27K after10b5-1
Jun 28, 2024 (view filing)Jun 262 daysAfeyan NoubarDirectorSSale−15.0K$127.22−$1.91M−0.7%2.28M after10 lots10b5-1
Jun 21, 2024 (view filing)Jun 183 daysAfeyan NoubarDirectorSSale−15.0K$133.57−$2.00M−0.6%2.30M after5 lots10b5-1
Jun 18, 2024 (view filing)Jun 171 dayHoge StephenPresidentSSale−15.0K$138.16−$2.07M−1.0%1.46M after10b5-1
Jun 14, 2024 (view filing)Jun 122 daysAfeyan NoubarDirectorSSale−15.0K$147.20−$2.21M−0.6%2.31M after8 lots10b5-1
Jun 11, 2024 (view filing)Jun 101 dayKlinger Shannon ThymeChief Legal OfficerSSale−5.18K$148.09−$766.8K−24.5%15.9K after10b5-1
Jun 11, 2024 (view filing)Jun 11Same dayAfeyan NoubarDirectorSSale−202.8K$148.33−$30.1M−11.7%1.53M after4 lots
Jun 7, 2024 (view filing)Jun 52 daysAfeyan NoubarDirectorSSale−15.0K$151.25−$2.27M−0.8%1.95M after9 lots10b5-1
Jun 4, 2024 (view filing)Jun 31 dayMock James MChief Financial OfficerSSale−691$140.72−$97.2K−9.6%6.51K after10b5-1
Jun 4, 2024 (view filing)Jun 31 dayHoge StephenPresidentSSale−339$140.72−$47.7K0.0%1.47M after10b5-1
Jun 4, 2024 (view filing)Jun 31 dayKlinger Shannon ThymeChief Legal OfficerSSale−122$140.72−$17.2K−1.1%10.9K after10b5-1